The B-cell targeted CTA1-DD vaccine adjuvant is highly effective at enhancing antibody as well as CTL responses
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nils Y. Lycke |
| Publication date | February 1, 2001 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |